Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing tags : Approval save search
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
granted approval cancer treatment for
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Published: 2024-04-23 (Crawled : 07:00) - biospace.com/
IBRX | $5.175 -5.74% 3.8M
|
Manufacturing
|
| O: 16.59%
H: 0.65%
C: -10.73%
il-15 anktiva fda agonist approval bladder cancer for
Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.504 -13.03% 230K
|
Manufacturing
|
| O: 3.23%
H: 0.16%
C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study
Rail Vision Received Approval from Alstom to Install the AI Main Line system on its Locomotives
Published: 2024-03-26 (Crawled : 13:30) - globenewswire.com
RVSN | $1.11 0.91% 440K
|
n/a
|
| O: 7.5%
H: 0.0%
C: -14.53%
ALSMY | News | $1.63 430K
|
Manufacturing
|
| O: 0.71%
H: 1.42%
C: 1.42%
approval system vision
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
PLUR | $5.0 260
|
Manufacturing
|
| O: 0.0%
H: 0.99%
C: -4.1%
patent approval cell technology
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
acthar fda drug approval gel application
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 0.05%
H: 0.69%
C: 0.44%
biotechnologies approval agreement
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
Published: 2024-02-14 (Crawled : 12:30) - prnewswire.com
IINN | $1.9 2.15% 110K
|
Manufacturing
|
| O: 86.46%
H: 9.5%
C: -27.37%
first patent approval blood system
Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
Published: 2024-01-17 (Crawled : 12:30) - globenewswire.com
IXHL | $2.28 18K
|
Manufacturing
|
| O: 7.19%
H: 0.0%
C: -6.29%
ihl-42 drug approval ihl-42x trial
Proterra Receives Court Approval for Sale of Proterra Transit Business Line
Published: 2024-01-08 (Crawled : 22:00) - globenewswire.com
PTRAQ | $0.012 16.67% 310K
|
Manufacturing
|
| O: 26.09%
H: 0.34%
C: -13.45%
MC | $53.89 -1.3% 380K
|
Finance
|
| O: -1.78%
H: 0.24%
C: -0.73%
business approval proterra
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
Published: 2023-12-12 (Crawled : 21:00) - globenewswire.com
RSLS | $0.1705 42K
|
Manufacturing
|
| O: 59.44%
H: 47.43%
C: -3.95%
lifesciences fda approval
Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma
Published: 2023-12-12 (Crawled : 13:00) - globenewswire.com
HUMA | $3.805 -3.18% 1M
|
Manufacturing
|
| O: 0.36%
H: 2.18%
C: -0.36%
fda license approval treatment application
Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder
Published: 2023-12-07 (Crawled : 23:00) - prnewswire.com
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKTQ | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
inomax fda approval clearance system
IceCure's ProSense® Deepens Regulatory Approval in India
Published: 2023-11-29 (Crawled : 19:00) - biospace.com/
ICCM | $1.22 55K
|
Manufacturing
| Email alert
Add to watchlist
prosense approval india
Proterra Receives Court Approval for Sale of Proterra Powered Business Line
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
PTRAQ | $0.012 16.67% 310K
|
Manufacturing
|
| O: -1.06%
H: 9.64%
C: -0.71%
MC | $53.89 -1.3% 380K
|
Finance
|
| O: 0.99%
H: 2.35%
C: 0.66%
business approval proterra
IntelGenx Announces Shareholder Approval of Financing Transactions
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
IGXT | $0.1639 400K
|
Manufacturing
|
| O: -2.37%
H: 4.17%
C: -6.94%
approval
Almirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis
Published: 2023-11-17 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.71%
H: 0.0%
C: 0.0%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
ebglyss dermatitis approval
IntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease
Published: 2023-11-14 (Crawled : 12:30) - globenewswire.com
IGXT | $0.1639 400K
|
Manufacturing
|
| O: 7.74%
H: 1.85%
C: -0.96%
versafilm disease parkinson's approval montelukast trial phase 2
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
Published: 2023-10-24 (Crawled : 13:00) - globenewswire.com
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
| Email alert
Add to watchlist
approval treatment global hiv commercial
HeliFlite Granted FAA Approval for International Expansion in the Bahamas and Caribbean
Published: 2023-10-23 (Crawled : 16:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -3.81%
H: 0.0%
C: 0.0%
granted approval international expansion
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.